Press Release

Pernix Therapeutics to Present at Needham & Company’s 15th Annual Healthcare Conference

MORRISTOWN, N.J., April 05, 2016 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that Doug Drysdale, Chairman and Chief Executive Officer, and Sanjay Patel, Chief Financial Officer, will present at Needham & Company’s 15th Annual Healthcare Conference, as follows.

Date:   Wednesday, April 13, 2016
Time:   3:00 PM EDT 
Location:   New York, NY - Westin New York Grand Central Hotel

About Pernix Therapeutics

Pernix Therapeutics is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market. The Company targets underserved therapeutic areas such as CNS, including neurology and pain management, and has an interest in expanding into additional specialty segments. The Company promotes its branded products to physicians through its Pernix sales force and markets its generic portfolio through its wholly owned subsidiaries, Macoven Pharmaceuticals, LLC and Cypress Pharmaceutical, Inc.

To learn more about Pernix Therapeutics, visit

Investor Relations
Sanjay Patel, (800) 793-2145 ext. 1009
Chief Financial Officer

Matthew P. Duffy, 212.915.0685
LifeSci Advisors, LLC

Primary Logo

Pernix Therapeutics Holdings, Inc.